← Human Trials & Peer-Reviewed Studies
Nicotine dependence measures among adolescents with psychiatric disorders: evaluating symptom expression as a function of dependence severity.
Plain-language guide to PMID 14577990 (2003): clinical trial of Therapeutic nicotine (patch, non-peptide) in 191 adolescents.
Key Facts
- PMID
- 14577990
- Journal
- Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
- Year
- 2003
- Study type
- Clinical Trial
- Authors
- Strong DR et al. (4 authors)
- DOI
- 10.1080/1462220031000158609
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a clinical trial.
Using methods based in item response theory, the researchers examined a structured interview assessment of Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) nicotine dependence and the Modified Fagerström Tolerance Questionnaire (mFTQ) symptoms to explore the expression of particular symptoms as a function of level of nicotine involvement in a sample of 191 adolescents with psychiatric disorders.
This paper describes the relative severity of DSM-IV and mFTQ items, as well as each item's ability to discriminate among individuals at various levels of nicotine involvement.
Who Took Part
The abstract describes 191 adolescents taking part.
By PubMed's age tags, the people studied were children and teenagers, both men and women.
What Was Measured
Using methods based in item response theory, the researchers examined a structured interview assessment of Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) nicotine dependence and the Modified Fagerström Tolerance Questionnaire (mFTQ) symptoms to explore the expression of particular symptoms as a function of level of nicotine involvement in a sample of 191 adolescents with psychiatric disorders.
This paper describes the relative severity of DSM-IV and mFTQ items, as well as each item's ability to discriminate among individuals at various levels of nicotine involvement.
The subject headings attached to it are Adolescent Behavior, Diagnostic and Statistical Manual of Mental Disorders, Disease Progression, Interview, Psychological, Mental Disorders, Psychometrics and Sensitivity and Specificity.
What This Means in Plain Language
This is a clinical trial of Therapeutic nicotine (patch, non-peptide) in 191 adolescents.
The publication is from 2003 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.
More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.
Our Notes on the Compound
Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.